Catherine Szyman on medical devices
From Patients should decide how easily medical records can be accessed: Masimo CEO · · CNBC Television
“If we hoarded our data and said our pulse oximeter data cannot be input into the infusion pump, then when the patient's overdosing and our pulse oximeter is dropping, that data doesn't get to the infusion pump and the infusion pump does not shut down the flow of opioids.”
On , Catherine Szyman, Chief Executive Officer & Director at MASIMO CORP, spoke about medical devices during Patients should decide how easily medical records can be accessed: Masimo CEO on CNBC Television.
About Catherine Szyman
Catherine Szyman, CEO and Director of Masimo, has been involved in discussions about the company’s strategic direction and product offerings. In September 2024, she addressed the challenge of integrating the company’s consumer health business with its healthcare-focused investor base, stating that “our healthcare investors don't know how to deal with the consumer side of our business” and that the company was exploring ways to separate the consumer health segment. She also highlighted the launch of a new hospital-grade pulse oximetry monitor for infants, priced around $200 to $300, which she described as a product that could “change everything” for parents monitoring their babies at home. Szyman has also advocated for greater interoperability of medical data. She argued that patients should decide how their medical records are accessed, stating that “privacy rules were there to protect patients not to potentially harm them” and that data sharing could save lives and reduce healthcare costs. She criticized electronic health records company Epic Systems for not sharing data, noting that “we used to be in the business of hoarding our data but what we realized is that patients were getting harmed because we were hoarding data.” She commended federal officials for pushing for data-sharing regulations, saying “it’s time to share the data.”